Since January 2000, The BMJ has not asked authors of journal articles to assign us their copyright. Authors (or their employers) retain their copyright in the article. All we require from authors is an exclusive licence (or, from government employees who cannot grant this, a non-exclusive licence) that allows us to publish the article in The BMJ (including any derivative products) and any other BMJ products (such as the Student BMJ or overseas editions), and allows us to sublicence such rights and exploit all subsidiary rights.
We ask the corresponding author to grant this exclusive licence (or non-exclusive for government employees) on behalf of all authors by reading our licence and inserting in the manuscript on submission the following statement:
“The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, a worldwide licence to the Publishers and its licensees in perpetuity, in all forms, formats and media (whether known now or created in the future), to i) publish, reproduce, distribute, display and store the Contribution, ii) translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or, abstracts of the Contribution, iii) create any other derivative work(s) based on the Contribution, iv) to exploit all subsidiary rights in the Contribution, v) the inclusion of electronic links from the Contribution to third party material where-ever it may be located; and, vi) licence any third party to do any or all of the above.”
This licence allows authors to use their own articles for their own non-commercial purposes without seeking permission from us. Only if the use is commercial do we need to know about it. In addition, we will pay authors a royalty on certain commercial uses that we negotiate.
Thus authors may use their own articles for the following non-commercial purposes without asking our permission (and subject only to acknowledging first publication in The BMJ and giving a full reference or web link, as appropriate).
On orders that we receive up to five years after publication for a single article reprint or translation sale that exceed £1500 in value, we will pay authors a royalty of 10% of net receipts less sales any commission, which will be paid to the Corresponding Author for distribution as agreed between the authors.
Anyone else (other than the author of a particular paper) who wants to reproduce an article from The BMJ needs to ask our permission. We are usually happy to give permission, though in many cases we will charge a fee.
Permission should be sought by following the Request permissions link that appears in the right hand panel on every article, or under its entry in a table of contents. This will take you to the Rightslink electronic request system.
Details about reprints can be obtained here.
The BMJ’s open access articles are all the research articles that we publish (irrespective of who funded the research) and any other article based on work funded by a funding organisation that requires open access publication—that is, requires its grant recipients to deposit publications arising out of the funded work to be deposited in PubMed Central open access repository.
By default, we publish these articles under a Creative Commons Attribution Non Commercial (CC BY-NC 4.0) licence that allows reuse subject only to the use being non-commercial and to the article being fully attributed (http://creativecommons.org/licenses/by-nc/4.0). Articles funded by certain organisations (currently RCUK and the Wellcome Trust) that mandate publication with a Creative Commons Attribution (CC BY 4.0) licence, which permits reuse for commercial purposes subject to the article being fully attributed (http://creativecommons.org/licenses/by/4.0) are published with this licence. The BMJ makes all open access articles freely available on thebmj.com from the date of publication and at the same time sends them to PubMed Central (see below).
Open access articles can be identified by the Creative Commons copyright statement that appears at the end of the article and takes the following form:
“This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0.”
“This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0.”
The BMJ also sends these articles, without further intervention from the author, to PubMed Central, the National Library of Medicine’s full text article archive, where they are made fully available in PubMed’s open access subset.
The PubMed Central open access subset is a subset of the total collection of articles in PubMed Central. These articles “are still protected by copyright, but are made available under a Creative Commons or similar license that generally allows more liberal redistribution and reuse than a traditional copyrighted work.” For all research articles except those funded by RCUK and the Wellcome Trust, the BMJ licence allows reuse with attribution of the origin of the article (a full citation) for non-commercial or use only, unless the research was funded by an organisation that mandates. For commercial use our normal permissions policy applies.
The full text of every research article published in The BMJ is immediately accessible on thebmj.com through open access, for everyone. The BMJ is committed to keeping research articles open access, with Creative Commons licences and deposit of the full text content in PubMedCentral as well as full open access on thebmj.com. To support this we are now asking all authors to pay an open access fee of £3000 on acceptance of their paper. We do have a waiver policy for authors who cannot pay. Consideration of research articles is not related to ability to pay the fee, and we ask authors not to discuss with editors any issues concerning payment at any stage of the peer review process. Any communications related to fees are handled by administrative staff not involved in decisions about manuscripts.
Research articles, and any other type of article funded by a funder that mandates open access publication, are published under a Creative Commons Licence. For non-research articles published with open access we will ask authors to pay the open access fee, as explained above.